HDAX Therapeutics

Augustine Therapeutics

This company develops small molecule inhibitors to treat patients with neuromuscular, neurodegenerative and cardio-metabolic diseases.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

HuntX Pharma

This biotechnology firm develops oral small-molecule therapeutics targeting axonal transport defects to treat patients with Huntington's disease and other neurodegenerative disorders.

Revier Therapeutics

This company develops orally available small molecules targeting class IIa histone deacetylases to treat patients with heart failure and atherosclerotic cardiovascular diseases.

Hoba Therapeutics

This biotech company develops therapeutic proteins and non-opioid compounds to treat patients suffering from chronic neuropathic pain and sensorineural hearing loss.

Yumanity Therapeutics

This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.

Hoba Therapeutics ApS

This biotech company develops therapeutic proteins to treat patients suffering from chronic neuropathic pain and sensorineural hearing loss.

Brano Therapeutics

This company develops small-molecule inhibitors to treat heart failure and metabolic dysfunction for patients with cardiovascular diseases.